2019
Jul - Dr. Stiles named to NIH/NINDS Special Emphasis Panel
Apr - Phase 1B NIH grant received to develop MS therapeutic
Jul - Dr. Stiles named to NIH/NINDS Special Emphasis Panel
Apr - Phase 1B NIH grant received to develop MS therapeutic
Founder | CEO